The Prevalence Of Hematologic Adverse Events (Haes) And Myelodysplastic Syndrome/Acute Myeloid Leukemia (Mds/Aml) In Patients (Pts) With Advanced High Grade Ovarian Carcinoma (Ahgoc) Receiving Parp Inhibitor (Parpi), With Or Without A Germline Brca Pathogenic Variant
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: The Prevalence Of Hematologic Adverse Events (Haes) And Myelodysplastic Syndrome/Acute Myeloid Leukemia (Mds/Aml) In Patients (Pts) With Advanced High Grade Ovarian Carcinoma (Ahgoc) Receiving Parp Inhibitor (Parpi), With Or Without A Germline Brca Pathogenic Variant ### Output: 